Dr. Ashish K. Jha
Co-Founder & CEO, BioRadar; Senior Fellow, Harvard Belfer Center for Science and International Affairs; Former White House COVID-19 Response Coordinator
Dr. Ashish K. Jha
Co-Founder & CEO, BioRadar; Senior Fellow, Harvard Belfer Center for Science and International Affairs; Former White House COVID-19 Response Coordinator
Check Fees And Availability for Dr. Ashish K. Jha
Biography
Dr. Ashish K. Jha is a physician, scientist, and biosecurity leader whose career spans government, academia, global health institutions and medical practice. He has served as White House COVID-19 Response Coordinator, as Dean of the Brown University School of Public Health, and as a trusted advisor to policymakers and institutions at the highest levels. Across these roles, he has helped leaders make consequential decisions, manage complex crises, and translate evidence into effective policy. Throughout his career, he has worked with leaders across the political spectrum to advance practical, evidence-based solutions.
Today, Dr. Jha’s work focuses on the future of healthcare, including artificial intelligence, health system transformation, biosecurity, climate and health, healthcare affordability, and rebuilding trust in science and medicine.
Dr. Jha is Co-Founder and CEO of BioRadar, a biointelligence company building biological threat detection infrastructure. Drawing on the lessons from his experience leading the nation’s COVID-19 response, BioRadar is developing the capability to identify emerging biological threats before they become crises — the equivalent of a national weather service for biology, rather than a fire department that arrives once the building is already burning.
Dr. Jha served as Dean of the Brown University School of Public Health. Prior to Brown, he was the K.T. Li Professor of Global Health at the Harvard T.H. Chan School of Public Health, Professor of Medicine at Harvard Medical School, and Director of the Harvard Global Health Institute.
He is currently a Senior Fellow in Emerging Technology, Scientific Advancement, and Global Policy at Harvard Kennedy School’s Belfer Center for Science and International Affairs.
A longtime leader in pandemic preparedness and response, Dr. Jha has directed pioneering research on Ebola, led national and international public health efforts, and advised numerous domestic and global institutions, including the OECD, the Pontifical Academies, and the National Academy of Medicine. In March 2022, President Joe Biden appointed him White House COVID-19 Response Coordinator, calling him “one of the leading public health experts in America.” In that role, Dr. Jha expanded access to treatments and updated vaccines, strengthened testing and surveillance, rebuilt the national stockpile, and drove major investments in indoor air quality. He also helped establish durable infrastructure to confront future biological threats, earning bipartisan praise for his pragmatic leadership.
Dr. Jha is among the most highly cited health scholars in the United States, with more than 300 publications in leading journals, including The Lancet, The New England Journal of Medicine, JAMA, and The BMJ. His work has been cited more than 56,000 times, and he has consistently been ranked among the top 1% of most-cited researchers globally. His research focuses on improving the quality and affordability of care through policy innovation in the United States and around the world.
Dr. Jha appears regularly at public forums and is sought out by the news media for timely, well-informed commentary on a wide range of health topics. He has testified before the U.S. Congress and numerous state legislatures.
Known for translating complex scientific, medical, and policy issues into clear, practical insights, Dr. Jha delivers timely, solutions-oriented presentations grounded in rigorous evidence and real-world experience. Speaking to corporations, healthcare organizations, universities, associations, and government leaders, he helps audiences anticipate the forces shaping healthcare’s future and make better decisions in an increasingly complex world.
Speaker Videos
Leadership and Trust in the Age of Information Chaos
Preparing for the Next Pandemic
How AI has made me a better doctor
Comparing the U.S. healthcare system to the rest of the world
We are going to see more and more dangerous engineered pathogens
We are going to lose a whole generation of scientists
The Power of Evidence in Reforming US Healthcare
Speech Topics
Artificial Intelligence in Healthcare: How AI Is Transforming Medicine and What We Need to Get Right
Artificial intelligence is changing medicine, but better technology does not automatically lead to better care. Dr. Ashish K. Jha offers a clear-eyed assessment of where AI is already improving diagnosis, drug development, and clinical decision-making, as well as where its limitations create new risks. Drawing on his experience across medicine, technology, and health policy, Dr. Jha examines the importance of data quality, algorithmic bias, and patient trust as health systems adopt increasingly powerful tools. He also explores how leaders can evaluate AI responsibly, protect the role of human judgment, and ensure innovation improves outcomes rather than deepening existing disparities. This timely keynote provides a practical roadmap for using AI safely and effectively while keeping patients at the center of healthcare.
Audiences will learn:
Where AI is creating meaningful value across healthcare
Why data quality, bias, and trust must guide implementation
How health leaders can adopt AI without losing sight of patient care
Leading Before Certainty: Making High-Stakes Decisions in a Crisis
In a crisis, leaders rarely have the luxury of complete information. They must make consequential decisions while the facts are changing, expert advice conflicts, operational systems are under strain, and public scrutiny is intense. Drawing on his experience as White House COVID-19 Response Coordinator, and on his current work as Co-Founder and CEO of BioRadar, Dr. Ashish K. Jha examines what effective leadership looks like when certainty is impossible and delay carries real costs. He explores how leaders can distinguish uncertainty from indecision, integrate competing forms of expertise, build disciplined systems for rapid decision-making, and keep their teams aligned as the evidence shifts. Crisis leadership, he argues, depends less on personal instinct than on building teams and institutions capable of learning and adapting in real time. Practical, candid, and deliberately nonpartisan, this keynote offers a framework for leading through disruption and making better decisions under pressure.
Audiences will learn:
How to structure teams and information flows for speed and accountability
How to keep an organization aligned when the evidence changes mid-course
How to turn crisis experience into lasting organizational capability
A New Era of Biological Risk: Why America Needs a National Weather Service for Biology
Advances in artificial intelligence and synthetic biology are making it easier to create biological threats that existing surveillance systems will not recognize until it is too late. Dr. Ashish K. Jha, former White House COVID-19 Response Coordinator and Co-Founder and CEO of BioRadar, explains why the next major outbreak could look very different from the pandemics of the past. Drawing on his experience across medicine, government, technology, and crisis response, Dr. Jha argues that the United States has built a fire department for biological threats when what it needs is a national weather service — infrastructure that forecasts and warns rather than simply responds. He explains how smarter surveillance and stronger intelligence infrastructure can identify emerging threats earlier. He also explores the coordination, investment, and political commitment required to respond before an outbreak becomes a global emergency. Urgent but solutions-focused, this keynote shows that strengthening biological preparedness is both possible and essential.
Audiences will learn:
How AI and synthetic biology are rapidly changing the nature of biological threats
Why current surveillance systems will likely fail to detect engineered pathogens
What governments and health systems can do to improve early warning and preparedness
Health System Costs & Reform: How to Stop Healthcare Costs From Sinking Our Economy
America’s rising healthcare costs threaten far more than household budgets. They are placing enormous pressure on federal and state finances while crowding out investments in other national priorities. Dr. Ashish K. Jha cuts through competing claims to explain what is actually driving healthcare spending and why many proposed solutions fail to address the underlying problems. Drawing on his research on health system performance and on “Cost Cures: Fixing American Healthcare,” his multi-part Boston Globe series on healthcare affordability, Dr. Jha examines where costs can be reduced without sacrificing access, quality, or innovation. The result is a realistic, nonpartisan path toward a more affordable and sustainable health system, and a clear-eyed account of the choices and tradeoffs that meaningful reform will require.
Audiences will learn:
What is driving the continued rise in healthcare spending
Why common approaches to controlling costs often fall short
Which reforms could make healthcare more affordable and sustainable
Trust in Science & Medicine: Restoring Confidence Before the Next Crisis
Public health depends not only on scientific knowledge, but on whether people trust the institutions and experts delivering it. Dr. Ashish K. Jha examines how confidence in science and medicine eroded long before COVID-19 and why the pandemic deepened that divide. Speaking as someone who delivered national public health guidance under intense scrutiny, Dr. Jha explores how inconsistent messaging, institutional failures, and an unwillingness to acknowledge uncertainty have weakened public confidence. He offers a practical agenda for rebuilding trust through greater transparency, meaningful accountability, and more honest communication about what science knows and where questions remain. The talk makes the case that restoring trust is not merely a communications challenge; it is a precondition for protecting the public and preparing society for the next crisis.
Audiences will learn:
What has contributed to declining trust in science and medicine
How institutions can communicate uncertainty with greater honesty
What leaders can do to rebuild confidence before the next crisis